CClinicalTrials.gg
CompletedNCT04713579ToSCiNUpdated Jan 18, 2023

Timing of Stoma Closure in Neonates

An observational study in Enterocolitis, Necrotizing, Atresia; Bowel and Gastroschisis, sponsored by Manchester University NHS Foundation Trust. Completed at 1 site in United Kingdom. Per ClinicalTrials.gov, last updated 2023-01-18.

Sponsored by Manchester University NHS Foundation Trust · Observational

Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
56
Sex
All
01

Study summary

Some babies require emergency surgery on their tummy in the first few months of life. This is most commonly because they were born prematurely and developed a bowel problem (called NEC) or a blockage of the bowel. As part of this surgery, the ends of the bowel may be brought to the skin surface (called a stoma) to divert stool into a bag. The stoma allows time for the bowel to rest and recover and is intended to be temporary with reversal later on. The best time to reverse or "close" the stoma is unknown. Stomas may cause dehydration, poor growth and skin problems so earlier closure may be better; however surgery is safer when babies are older and bigger so later closure may be better.

This study aims to answer the question, 'is it feasible to conduct a clinical trial comparing 'early' vs. 'late' stoma closure in neonates?' It has a series of specific objectives which incorporate: (i) describing current UK practice; (ii) establishing whether or not a clinical trial (and exactly what form of trial) is acceptable to parents and clinicians; and (iii) establishing the design of a potential trial, including defining the intervention ('early vs. late') and the population of infants to be included, how infants should be recruited and what information should be collected (outcomes).

The investigators will ask parents and health professionals for their views and whether they would take part in a future trial and information about babies who have recently had a stoma to find out which factors influence the timing of closure. They will also analyse 6 years of data from an existing database, the National Neonatal Research Database to estimate the numbers of babies affected, understand current practice and outcomes for these babies to help decide whether a clinical trial is possible.

Read the detailed description

Neonates undergoing emergency abdominal surgery frequently require stoma formation. Reversing (closing) these stomas with a second operation is an essential part of the infant's recovery. The timing of this closure is highly variable around the United Kingdom (UK) and the best time remains unclear. Current evidence is of low methodological quality and presents mixed conclusions: determining the best time has significant potential benefits for: (i) infant health outcomes (short-term e.g. avoiding complications and long-term e.g. growth and neurodevelopment); ii) families (e.g. reduced Neonatal Intensive Care Unit (NICU) stay); and iii) healthcare providers (e.g. reduced costs). Ideally, a clinical trial to compare early and late closure would be conducted but this is likely to be challenging and may not be feasible or acceptable to parents and clinicians.

Aims and objectives:

This study aims to answer the question, 'is it feasible to conduct a clinical trial comparing 'early' vs. 'late' stoma closure in neonates?' It has a series of specific objectives which incorporate: (i) describing current UK practice; (ii) establishing whether or not a clinical trial (and exactly what form of trial) is acceptable to parents and clinicians; and (iii) establishing the design of a potential trial, including defining the intervention ('early vs. late') and the population of infants to be included, how infants should be recruited and what information should be collected (outcomes).

Methods:

The study will use a mixed-methods approach comprising three parallel workstreams (WS). WS 1 will be a national survey of clinician perspectives of neonatal stoma closure. WS 2 will use an observational cohort study, interviews, questionnaires and focus groups. WS 3 will analyse three existing large databases (National Neonatal Research Database (NNRD), Health Episode Statistics (HES) and British Association of Paediatric Surgeons Congenital Anomalies Surveillance System (BAPS-CASS)).

The findings of these WS will be combined and presented at a final, trial design meeting where conclusions about trial feasibility will be reached and if appropriate, an outline of a trial protocol agreed.

Anticipated impact and dissemination:

The principal impact will be determining whether or not a definitive trial can go ahead: if the study demonstrates that a trial is feasible then the investigators will use their findings to design a trial that is acceptable to parents and clinicians; that includes the most appropriate infants; that measures outcomes important to parents and clinicians and ultimately, answers the question: when is the best time to close an infant's stoma? Findings will be disseminated at national meetings of relevant professionals, through social media (including patient groups), to funding bodies and in open access publications.

02

Conditions studied

  • Enterocolitis, Necrotizing
  • Atresia; Bowel
  • Gastroschisis
  • Meconium Ileus
  • Premature Birth
  • Bowel Obstruction
  • Perforation Bowel

Keywords

  • Stoma closure
  • Infant
  • Neonatal
03

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Workstream 1: clinicians involved in caring for infants with stomas in UK surgical units.

Workstream 2.1: Infants who have had a stoma formed as part of emergency surgery before 44 weeks post-conceptual age.

Workstream 2.2: clinicians involved in caring for infants recruited to WS 2.1.

Workstream 2.3: Parents of premature and term infants who have had an stoma in the last three years; clinicians in participating surgical units, who are involved in the treatment of infants requiring emergency stoma closure.

Eligibility criteria

Workstream 1

Inclusion criteria:

  • Neonatologists in surgical NICUs, neonatal surgeons, neonatal dieticians and neonatal surgical nurses.

Workstream 2.1

Inclusion criteria:

  • Infants having a stoma as part of emergency surgery before 44 weeks post-conceptual age: Group A preterm infants who have stomas formed for necrotising enterocolitis, spontaneous intestinal perforation or other intestinal pathology, and Group B infants (usually born closer to term) who have congenital anomalies that lead to bowel obstruction (e.g. intestinal atresias; meconium ileus and other conditions such as complicated gastroschisis).

Exclusion criteria:

  • Cases where a stoma is part of a planned treatment pathway e.g. for an anorectal malformation or Hirschsprung's disease.
  • Infants who have a stoma formed after 44 weeks post-conceptual age.

Workstream 2.2

Inclusion criteria:

  • Lead surgeons and neonatologists caring for infants recruited to WS 2.1.

Workstream 2.3

Inclusion criteria:

  • Parents of premature and term infants who have had an stoma in the last three years (including parents of infants recruited to WS 2.1).
  • Clinicians in participating surgical units, who are involved in the treatment of infants requiring emergency stoma closure.

Exclusion criteria:

  • Parents who do not speak English.
04

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
56 participants (actual)
Patient registry
No

Groups and cohorts

  • Premature infants

    Infants born prematurely requiring a stoma for condition such as necrotizing enterocolitis (NEC) or spontaneous intestinal perforation (SIP).

    Other: No intervention - observational study

  • Term Infants

    Infants born closer to term requiring a stoma e.g. for congenital causes of bowel obstruction such as intestinal atresia, gastroschisis or meconium ileus

    Other: No intervention - observational study

Interventions

  • OtherNo intervention - observational study

    There is no intervention in this study as it is purely observational.

05

What researchers measure

Primary outcomes

  1. Feasibility of a future trial comparing early and late stoma closure

    The key research question 'Is it feasible to conduct a clinical trial comparing 'early' vs. 'late' stoma closure in neonates?' will be answered by completing the series of secondary outcome measures using qualitative mixed research methods

    Time frame: through study completion, an average of 1 year

Secondary outcomes

  1. To establish current UK practice for stoma closure in neonates

    Find out what is currently happening in the UK for stoma closure in babies

    Time frame: through study completion, an average of 1 year

  2. To determine whether there is equipoise amongst clinicians (neonatal surgeons, and neonatologists) and allied health professionals (specialist nurses and dieticians) over when it is best to close stomas in neonates

    Find out whether surgeons, neonatal doctors and other professionals like dietitians are genuinely uncertain about when it is best for stomas to be closed

    Time frame: through study completion, an average of 1 year

  3. To determine the willingness of parents, neonatal surgeons and neonatologists to include neonates in a trial that would randomise to 'early' or 'late' stoma closure and identify potential barriers to recruitment.

    Find out if parents, surgeons and neonatal doctors would be willing to include babies in a trial that would randomly allocate them (like tossing a coin) to 'early' or 'late' stoma closure

    Time frame: through study completion, an average of 1 year

  4. To define 'early' and 'late' stoma closure for a potential trial.

    Decide what is meant by 'early' and 'late' stoma closure for a potential trial

    Time frame: through study completion, an average of 1 year

  5. Identify a group of babies for inclusion in a trial and find out how many of these babies could be included in the UK.

    To define a population of neonates for inclusion in a trial (in whom there is significant uncertainty over timing) and determine how many babies are eligible for inclusion.

    Time frame: through study completion, an average of 1 year

  6. Find the most appropriate design for a potential trial

    To establish the most appropriate design and outcome measures for a trial.

    Time frame: through study completion, an average of 1 year

  7. To assess the suitability of using routinely collected data for gathering clinical information for a trial.

    Find out if current national databases could be used for gathering the required information for a potential trial

    Time frame: through study completion, an average of 1 year

06

Study locations

1 site
  • Manchester University NHS Foundation Trust
    Manchester, United Kingdom
07

Registry details

Key details

Study ID
NCT04713579
Lead sponsor
Manchester University NHS Foundation Trust
Collaborators
University of Oxford, University of Liverpool
Responsible party
Sponsor
First posted
Jan 19, 2021
Start date
Feb 17, 2021
Primary completion
Oct 31, 2022
Completion
Oct 31, 2022
Last update
Jan 18, 2023

Study contacts

Nick Lansdale, MB FRCS PhD
principal investigator · Manchester University NHS Foundation Trust

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion